Do you or someone you know suffer from Chronic Limb-Threatening Ischemia? (CLTI)
Also known as Critical Limb Ischemia (CLI)
Discover a potential treatment option with BioGenCell’s BGC101!
Join Our Trial Today or Refer
a Family Member of a Friend
Learn More About BioGenCell’s
Groundbreaking TRACT Solution
How Does it Work?
BioGenCell Cell-Therapy Transforms Your Own Blood into Your Personalized Medicine - in 3 Steps!
We harness the incredible power of cell therapy and immunity to provide you with a 3-step treatment:
We Know that CLI Leads
to Extreme Suffering
CLI decreases patients’ quality of life and restricts their functionality. BioGenCell is committed to finding a solution that could change this reality.
BioGenCell’s team works to improve the condition of CLI patients through break-through cell-therapy treatments that are accessible, clinician-friendly and patient-friendly.
Great Benefits for CLI Patients
Our unique and advanced cell therapy methodology is based on immune cells and stem cells and is intended for those suffering from CLI and PAD.
In a rapid, one-time treatment, a patient’s blood is collected and the cells are returned to the patient after a short procedure, with the goal of achieving amputation free 12 months survival.
The Advantages of the BioGenCell Treatment
Easy to Use
Patients Don’t Have to Suffer Anymore!
Success in CLI Patients
BGC101 was found safe in the Hind Limb Ischemia (HLI) preclinical model of CLI.
Quality of Life*
* 6 months results from first, in human, open-labeled study in 5 no-option patients.